Clinical Trial Update: Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain [Phase 3]

View source ↗

Summary

Update on a Phase 3 trial evaluating reduced-dose versus standard-dose radiotherapy for nasopharyngeal carcinoma. The study is sponsored by Sun Yat-sen Universi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING